Oxford Nanopore Technologies PLC
Company Profile
Business description
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Contact
Edmund Halley Road
Gosling Building, Oxford Science Park
OxfordOxfordshireOX4 4DQ
GBRT: +44 8450347900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,315
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,133.10 | 6.20 | 0.08% |
| CAC 40 | 7,804.63 | 71.73 | -0.91% |
| DAX 40 | 22,189.46 | 350.52 | -1.56% |
| Dow JONES (US) | 41,989.96 | 11.80 | -0.03% |
| FTSE 100 | 8,566.35 | 68.45 | -0.79% |
| HKSE | 23,202.53 | 4.31 | -0.02% |
| NASDAQ | 17,449.89 | 150.60 | 0.87% |
| Nikkei 225 | 35,725.87 | 101.39 | 0.28% |
| NZX 50 Index | 12,320.19 | 7.59 | 0.06% |
| S&P 500 | 5,633.07 | 21.22 | 0.38% |
| S&P/ASX 200 | 7,934.50 | 9.30 | 0.12% |
| SSE Composite Index | 3,350.13 | 1.69 | 0.05% |